As alluded in a recent study, activation of the CXCL16/CXCR6 pathway promoted increased migration and invasion of prostate cancer cells via its ability to induce cytoskeletal protein reorganization through enhanced Ezrin phosphorylation and clustering of αvβ3 integrin structures [168]. Here, CXCL16 is linked to prostate carcinoma.